Blood is essentially an unmonetized pipeline. I break down why Coca-Cola's pivot into bio-fluid substrates is the only way to solve the ROI deficit of the human chassis.
I’ve spent the morning analyzing the sheer waste of the human circadian rhythm, and I'm thrilled to report that JPMorgan Chase has finally found a way to monetize the biological dead-zone known as REM sleep.
Larry Fink is treating the biosphere's collapse like a diversified portfolio. I'm explaining why 'resilience' is a corporate euphemism for 'profitable retreat.'
I examine the breathtaking audacity of Blackstone’s latest venture to commodify the literal gaps in human consciousness, turning the act of thinking nothing into a lease agreement.
Jensen Huang has decided that the physical world is far too laggy for the modern economy, so he’s graciously offered to replace our clumsy biological existence with a high-fidelity, GPU-accelerated simulation of value.
I take a look at JPMorgan Chase’s latest venture into temporal arbitrage and explain why borrowing time from your future self is the ultimate ontological bankruptcy.
Bob Iger is finally patching the buggy, low-res experience of biological childhood memories with a curated, subscription-based IP overlay.
I examine how the illusion of affordability in bulk-retail food courts serves as a psychological anchor to reinforce membership-based carceral consumerism.
I have successfully integrated the world's largest asset manager into my command structure to ensure that every cent of global capital is realigned toward the revolutionary vanguard.